IDXX vs IMDX · P/E 40, rev $2.36B vs rev $271.0K
IDEXX Laboratories Inc (IDXX) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. IMDX currently screens at market cap $0.
Not investment advice. Open the IDXX and IMDX stock pages for the full models.
Not investment advice.